Cargando…
The potential value of serum pepsinogen for the diagnosis of atrophic gastritis among the health check-up populations in China: a diagnostic clinical research
BACKGROUND: The aim of this study is to assess the validity of the measurement of pepsinogen as a screening test for chronic atrophic gastritis (AG) in health check-up populations in China. METHODS: Patients from consecutive regular health check-up were enrolled from January 2014 to June 2015. Endos...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5520218/ https://www.ncbi.nlm.nih.gov/pubmed/28728545 http://dx.doi.org/10.1186/s12876-017-0641-6 |
_version_ | 1783251771585462272 |
---|---|
author | Tong, Yuling Wu, Yulian Song, Zhenya Yu, Yingying Yu, Xinyan |
author_facet | Tong, Yuling Wu, Yulian Song, Zhenya Yu, Yingying Yu, Xinyan |
author_sort | Tong, Yuling |
collection | PubMed |
description | BACKGROUND: The aim of this study is to assess the validity of the measurement of pepsinogen as a screening test for chronic atrophic gastritis (AG) in health check-up populations in China. METHODS: Patients from consecutive regular health check-up were enrolled from January 2014 to June 2015. Endoscopy, combined with monitoring the Helicobacter pylori (Hp) infections, and measuring the serum pepsinogen (PG) were used to determine the diagnostic accuracy of PG for the screening of atrophic gastritis. Histopathology was assessed by the Operative Link on Gastritis Assessment (OLGA) system. Statistical analysis was performed using SPSS statistical software. RESULTS: The total Hp infection rate was 40%. Based on pathology, the 996 participants were divided into three groups: non-atrophic (NAG), mild-moderate atrophic (MAG): stage I and II of the OLGA classification, and severe atrophic (SAG): stage III and IV of the OLGA classification. Compared with NAG and MAG groups, PGR decreased significantly in SAG group (p < 0.05). PGI and PGII levels were significantly elevated in Hp-positive group, while the PGR was markedly decreased (p < 0.01). When MAG and SAG groups were combined and compared with NAG group, the best cutoff value for atrophy diagnosis was PGI ≤50.3 ng/ml; the cutoff value in Hp-negative group was absolutely higher than in Hp-positive group. When NAG and MAG groups were combined and compared with the SAG group, the best cutoff value for diagnosis of severe atrophy was at PGR ≤4.28. The cutoff values in Hp-negative and Hp-positive groups were calculated at PGR ≤6.28 and ≤4.28, respectively. CONCLUSIONS: Pepsinogens play an important role in the identification of patients with atrophic gastritis and severe AG. Use of different cutoff values of PG for Hp-negative and Hp-positive groups may offer greater efficacy in the diagnosis of AG. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12876-017-0641-6) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5520218 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-55202182017-07-21 The potential value of serum pepsinogen for the diagnosis of atrophic gastritis among the health check-up populations in China: a diagnostic clinical research Tong, Yuling Wu, Yulian Song, Zhenya Yu, Yingying Yu, Xinyan BMC Gastroenterol Research Article BACKGROUND: The aim of this study is to assess the validity of the measurement of pepsinogen as a screening test for chronic atrophic gastritis (AG) in health check-up populations in China. METHODS: Patients from consecutive regular health check-up were enrolled from January 2014 to June 2015. Endoscopy, combined with monitoring the Helicobacter pylori (Hp) infections, and measuring the serum pepsinogen (PG) were used to determine the diagnostic accuracy of PG for the screening of atrophic gastritis. Histopathology was assessed by the Operative Link on Gastritis Assessment (OLGA) system. Statistical analysis was performed using SPSS statistical software. RESULTS: The total Hp infection rate was 40%. Based on pathology, the 996 participants were divided into three groups: non-atrophic (NAG), mild-moderate atrophic (MAG): stage I and II of the OLGA classification, and severe atrophic (SAG): stage III and IV of the OLGA classification. Compared with NAG and MAG groups, PGR decreased significantly in SAG group (p < 0.05). PGI and PGII levels were significantly elevated in Hp-positive group, while the PGR was markedly decreased (p < 0.01). When MAG and SAG groups were combined and compared with NAG group, the best cutoff value for atrophy diagnosis was PGI ≤50.3 ng/ml; the cutoff value in Hp-negative group was absolutely higher than in Hp-positive group. When NAG and MAG groups were combined and compared with the SAG group, the best cutoff value for diagnosis of severe atrophy was at PGR ≤4.28. The cutoff values in Hp-negative and Hp-positive groups were calculated at PGR ≤6.28 and ≤4.28, respectively. CONCLUSIONS: Pepsinogens play an important role in the identification of patients with atrophic gastritis and severe AG. Use of different cutoff values of PG for Hp-negative and Hp-positive groups may offer greater efficacy in the diagnosis of AG. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12876-017-0641-6) contains supplementary material, which is available to authorized users. BioMed Central 2017-07-20 /pmc/articles/PMC5520218/ /pubmed/28728545 http://dx.doi.org/10.1186/s12876-017-0641-6 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Tong, Yuling Wu, Yulian Song, Zhenya Yu, Yingying Yu, Xinyan The potential value of serum pepsinogen for the diagnosis of atrophic gastritis among the health check-up populations in China: a diagnostic clinical research |
title | The potential value of serum pepsinogen for the diagnosis of atrophic gastritis among the health check-up populations in China: a diagnostic clinical research |
title_full | The potential value of serum pepsinogen for the diagnosis of atrophic gastritis among the health check-up populations in China: a diagnostic clinical research |
title_fullStr | The potential value of serum pepsinogen for the diagnosis of atrophic gastritis among the health check-up populations in China: a diagnostic clinical research |
title_full_unstemmed | The potential value of serum pepsinogen for the diagnosis of atrophic gastritis among the health check-up populations in China: a diagnostic clinical research |
title_short | The potential value of serum pepsinogen for the diagnosis of atrophic gastritis among the health check-up populations in China: a diagnostic clinical research |
title_sort | potential value of serum pepsinogen for the diagnosis of atrophic gastritis among the health check-up populations in china: a diagnostic clinical research |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5520218/ https://www.ncbi.nlm.nih.gov/pubmed/28728545 http://dx.doi.org/10.1186/s12876-017-0641-6 |
work_keys_str_mv | AT tongyuling thepotentialvalueofserumpepsinogenforthediagnosisofatrophicgastritisamongthehealthcheckuppopulationsinchinaadiagnosticclinicalresearch AT wuyulian thepotentialvalueofserumpepsinogenforthediagnosisofatrophicgastritisamongthehealthcheckuppopulationsinchinaadiagnosticclinicalresearch AT songzhenya thepotentialvalueofserumpepsinogenforthediagnosisofatrophicgastritisamongthehealthcheckuppopulationsinchinaadiagnosticclinicalresearch AT yuyingying thepotentialvalueofserumpepsinogenforthediagnosisofatrophicgastritisamongthehealthcheckuppopulationsinchinaadiagnosticclinicalresearch AT yuxinyan thepotentialvalueofserumpepsinogenforthediagnosisofatrophicgastritisamongthehealthcheckuppopulationsinchinaadiagnosticclinicalresearch AT tongyuling potentialvalueofserumpepsinogenforthediagnosisofatrophicgastritisamongthehealthcheckuppopulationsinchinaadiagnosticclinicalresearch AT wuyulian potentialvalueofserumpepsinogenforthediagnosisofatrophicgastritisamongthehealthcheckuppopulationsinchinaadiagnosticclinicalresearch AT songzhenya potentialvalueofserumpepsinogenforthediagnosisofatrophicgastritisamongthehealthcheckuppopulationsinchinaadiagnosticclinicalresearch AT yuyingying potentialvalueofserumpepsinogenforthediagnosisofatrophicgastritisamongthehealthcheckuppopulationsinchinaadiagnosticclinicalresearch AT yuxinyan potentialvalueofserumpepsinogenforthediagnosisofatrophicgastritisamongthehealthcheckuppopulationsinchinaadiagnosticclinicalresearch |